SEE CORRESPONDING ARTICLE ON PAGE 536
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Biological Psychiatry: Cognitive Neuroscience and NeuroimagingAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Personalizing repetitive transcranial magnetic stimulation parameters for depression treatment using multimodal neuroimaging.Biol Psychiatry Cogn Neurosci Neuroimaging. 2022; 7: 536-545
- Repetitive transcranial magnetic stimulation for the acute treatment of major depressive episodes: A systematic review with network meta-analysis.JAMA Psychiatry. 2017; 74: 143-152
- Stanford Neuromodulation Therapy (SNT): A double-blind randomized controlled trial.Am J Psychiatry. 2022; 179: 132-141
- The intervention, the patient and the illness – Personalizing non-invasive brain stimulation in psychiatry.Exp Neurol. 2021; 341: 113713
- Smoking cessation induced by deep repetitive transcranial magnetic stimulation of the prefrontal and insular cortices: A prospective, randomized controlled trial.Biol Psychiatry. 2014; 76: 742-749
- Transcranial direct current stimulation vs sham stimulation to treat aphasia after stroke: A randomized clinical trial.JAMA Neurol. 2018; 75: 1470-1476
- Parsing the antidepressant effects of non-invasive brain stimulation and pharmacotherapy: A symptom clustering approach on ELECT-TDCS.Brain Stimul. 2021; 14: 906-912
- An adaptive seamless phase II/III clinical trial design incorporating short-term endpoint information.Trials. 2011; 12: A2
- Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic.Lancet. 2021; 398: 1700-1712
Article Info
Publication History
Accepted:
March 9,
2022
Received:
March 8,
2022
Identification
Copyright
© 2022 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.
ScienceDirect
Access this article on ScienceDirectLinked Article
- Personalizing Repetitive Transcranial Magnetic Stimulation Parameters for Depression Treatment Using Multimodal NeuroimagingBiological Psychiatry: Cognitive Neuroscience and NeuroimagingVol. 7Issue 6
- PreviewRepetitive transcranial magnetic stimulation (rTMS) is a tool that can be used to administer treatment for neuropsychiatric disorders such as major depressive disorder, although the clinical efficacy is still rather modest. Overly general stimulation protocols that consider neither patient-specific depression symptomology nor individualized brain characteristics, such as anatomy or structural and functional connections, may be the cause of the high inter- and intraindividual variability in rTMS clinical responses.
- Full-Text
- Preview
